🔬 QRISK3 Algorithm Explained💊 NICE NG238 10% Statin Threshold🫀 10-Year CVD Probability & Heart Age🏥 NHS Health Check Integration
What Is QRISK Score NHS? Score Meaning, Ranges & Statin Guidelines
What is QRISK score NHS? In the United Kingdom, your NHS QRISK score is an evidence-based clinical calculation that estimates your percentage likelihood of suffering a life-threatening cardiovascular event—such as a stroke, heart attack, or transient ischaemic attack (TIA)—over the next 10 years. Used by general practitioners and nurses during routine health screenings, your QRISK score is the primary benchmark that determines whether you qualify for preventative cholesterol-lowering medication (statins) and targeted cardiovascular lifestyle interventions.
Slide to your known 10-year QRISK percentage score (or use a clinical preset) to explore the clinical meaning, NICE guideline NG238 statin thresholds, and recommended NHS primary care actions. If you need to calculate your score from scratch, use our dedicated QRISK Calculator NHS tool.
10.5%
55 yrs
💡 What Does a 10.5% Score Mean in Plain English?
In a group of 100 people with identical risk characteristics, approximately 10 or 11 will experience a heart attack or stroke within the next 10 years, while 89 or 90 will not.
0% (Low)10% (NICE Threshold)20%+ (High Risk)
Elevated Risk (≥10%)
Eligible for NHS Statin Discussion (NICE NG238)
Your score of 10.5% crosses the official National Institute for Health and Care Excellence (NICE) intervention threshold. At this risk level, your GP or clinical pharmacist is advised to discuss primary cardiovascular prevention.
Clinical Next Step: Book a routine consultation with your GP surgery to discuss initiating a low-to-moderate intensity statin (such as Atorvastatin 20mg daily) alongside intensive lifestyle modification targeting blood pressure and LDL cholesterol.
What Is a QRISK Score and How Does the NHS Use It?
What is a QRISK score? Developed jointly by medical researchers at the University of Nottingham and ClinRisk Ltd, the QRISK algorithm is a clinically validated cardiovascular disease (CVD) risk assessment tool. Rather than evaluating single biometric figures in isolation—such as looking only at cholesterol or blood pressure—the QRISK algorithm evaluates how multiple physiological, genetic, environmental, and demographic factors interact synergistically to elevate your likelihood of arterial thrombosis.
In everyday UK healthcare practice, an NHS QRISK score provides a single, easily interpretable figure: your 10-year percentage probability of developing one of the following major cardiovascular conditions:
Myocardial infarction: Acute coronary thrombosis, commonly known as a heart attack.
Ischaemic or haemorrhagic stroke: Interruption of blood flow to cerebral brain tissues.
🏥 Clinical Standard: The NHS Health Check Programme
Every adult living in England aged 40 to 74 with no prior history of cardiovascular disease or diabetes is invited every 5 years for a free NHS Health Check. During this appointment, your blood pressure, lipid profile (cholesterol ratio), and BMI are measured, and your GP software calculates your formal QRISK score automatically to guide preventative treatment.
By measuring risk over a 10-year window, the NHS can intervene years before symptoms manifest. Because conditions like high blood pressure and arterial plaque accumulation remain largely asymptomatic until an acute thrombosis occurs (as detailed in our guide to the signs of high blood pressure), QRISK acts as an essential diagnostic early warning system.
QRISK Score Meaning: Understanding the Three NHS Risk Brackets
Under UK clinical frameworks established by the National Institute for Health and Care Excellence (NICE), 10-year cardiovascular risk is stratified into three distinct therapeutic categories:
Low Risk
QRISK Score Under 10%
Probability: Less than a 1 in 10 chance of suffering a cardiovascular event over the next 10 years.
NHS Clinical Guidance: Routine preventative lifestyle advice. Statins are generally not recommended unless specific high-risk conditions exist. Continued participation in the 5-yearly NHS Health Check.
Elevated Risk
QRISK Score 10% to 19.9%
Probability: Between a 1 in 10 and 1 in 5 chance of a heart attack or stroke in the next decade.
NHS Clinical Guidance:The NICE Intervention Threshold. GPs offer primary prevention with Atorvastatin 20mg once daily, combined with targeted diet, exercise, and blood pressure optimization.
High Risk
QRISK Score 20% or Higher
Probability: A 1 in 5 chance or greater of a severe cardiovascular event over the next 10 years.
NHS Clinical Guidance: Urgent primary cardiovascular intervention. Strong clinical recommendation for statin therapy, annual cardiovascular reviews, aggressive systolic BP control (<140/90 mmHg), and diabetes screening.
QRISK3 10-Year Score
Risk Classification
10-Year Event Odds
NICE Guideline NG238 Recommendation
Monitoring Frequency
< 5.0%
Very Low Risk
Fewer than 1 in 20 people
Maintain healthy diet, active lifestyle, and non-smoking status
Every 5 years (NHS Health Check)
5.0% – 9.9%
Low Risk
Between 1 in 20 and 1 in 10 people
Proactive lifestyle optimization; monitor blood pressure and BMI
Every 5 years (or sooner if BP rises)
10.0% – 14.9%
Moderate / Elevated
Between 1 in 10 and 1 in 7 people
Offer Atorvastatin 20mg; lifestyle changes to cut risk >40%
Annual review with repeat lipids
15.0% – 19.9%
Moderate / Elevated
Between 1 in 7 and 1 in 5 people
Offer Atorvastatin 20mg; strict BP management and weight loss
What Is a Good QRISK Score? Absolute vs. Relative Heart Risk
When patients ask "what is a good QRISK score?", the answer depends entirely on chronological age.
Because age is the single most powerful mathematical variable in the QRISK algorithm—reflecting cumulative years of vascular wear, arterial wall thickening, and oxidative stress—it is mathematically impossible for an 80-year-old adult to receive an absolute score under 10%, even if they run marathons, have a healthy BMI of 22, and possess optimal blood pressure. Conversely, a 30-year-old heavy smoker with untreated Stage 2 hypertension might receive an absolute 10-year score of only 4% simply because severe heart attacks are rare in one's early thirties.
⚠️ The "Young Smoker" Fallacy: Why Absolute Score Alone Can Be Deceptive
A low absolute score in a young or middle-aged adult does not necessarily mean pristine cardiovascular health. A 35-year-old male with a 4% score might seem "safe", but compared to a healthy non-smoker of the same age with normal blood pressure (whose risk is 0.8%), his risk is 5 times higher. His biological blood vessels are aging at an accelerated rate, and without intervention, his score will skyrocket as he reaches his fifties.
Understanding "Heart Age" and Relative Risk
To make scores meaningful across all age cohorts, NHS doctors use two companion metrics:
Relative Risk: This compares your personal QRISK score to the average score of a healthy person of your exact age, biological sex, and ethnic group who has ideal clinical metrics (non-smoker, systolic blood pressure 120 mmHg, total-to-HDL ratio 3.5, and BMI 22). A relative risk of 1.0 means your arteries match optimal health; a relative risk of 2.5 means you are at two-and-a-half times higher risk than an ideal peer.
Estimated Heart Age: This calculation translates your statistical risk into biological years. If you are 48 years old but have an estimated heart age of 59, your current cardiovascular risk profile matches that of an average 59-year-old. Lowering your blood pressure using our blood pressure calculator targets or achieving a healthy BMI range directly lowers your heart age back toward your birth age.
QRISK3 Explained: How Does It Differ From QRISK2?
While you may still hear some healthcare professionals mention QRISK2, modern NHS clinical software systems (such as EMIS Web, SystmOne, and Vision) utilize QRISK3. QRISK3 represents a substantial scientific advancement, developed from an analysis of more than 10.5 million anonymised electronic health records from GP practices across the UK.
The primary reason QRISK3 was created was to eliminate systemic underestimation of risk in patients who suffer from chronic inflammatory conditions, mental health disorders, or kidney disease.
The 22 Clinical Variables Evaluated in QRISK3
The QRISK3 algorithm combines traditional lifestyle metrics with detailed medical history:
Core Demographic & Biometric Markers
Age & Biological Sex: Primary determinants of baseline biological risk.
Ethnicity: Accounts for higher CVD rates in South Asian cohorts.
Townsend Deprivation Index: UK postcode socioeconomic deprivation factor.
Atrial Fibrillation (AF): Irregular heart rhythm carrying high stroke risk.
Migraine with Aura: Linked to increased ischemic cerebral risk.
Why the 10% Statin Threshold Matters (NICE Guideline NG238)
Prior to 2014, the UK clinical threshold for initiating preventative statin therapy stood at a 20% 10-year risk. In 2014, following extensive health-economic modeling and large-scale meta-analyses by the Cholesterol Treatment Trialists’ Collaboration, NICE halved the threshold to 10% (re-confirmed in NICE guideline NG238).
💊 The Clinical Logic of the 10% Statin Threshold
At a 10% risk level, prescribing Atorvastatin 20mg daily is proven to reduce a patient's relative risk of heart attack and stroke by approximately 25% to 35%. This translates into substantial absolute protection: for every 100 people with a 10% risk who take a statin for 5 years, approximately 2 to 3 catastrophic strokes or heart attacks are directly prevented.
When you reach or exceed 10%, your NHS doctor will not simply write a prescription; under NICE shared decision-making protocols, they will discuss:
Lifestyle modifications first or concurrent: Exploring whether dietary changes, smoking cessation, and weight loss might lower your score without medication.
Baseline blood tests: Checking renal function, liver enzymes (ALT), and baseline non-HDL cholesterol before starting treatment.
Treatment target: Aiming for at least a 40% reduction in baseline non-HDL cholesterol after 3 months of therapy.
Addressing side-effect concerns: True statin-induced myopathy (muscle damage) is rare (<1 in 1,000), while mild aches can often be resolved by switching statin molecules or adjusting dosages.
Important Clinical Exceptions: When QRISK Should NOT Be Used
Although QRISK is an indispensable screening tool, NICE clinical guidance strictly specifies several clinical scenarios where QRISK should not be calculated because the patient is automatically classified as high risk:
Severe microvascular and macrovascular risk not captured by population models.
Offer Atorvastatin 20mg daily directly to all adults over 40 with Type 1 diabetes.
Severe Chronic Kidney Disease (eGFR <60)
Markedly increased cardiovascular mortality independent of traditional cholesterol metrics.
Offer Atorvastatin 20mg directly for primary prevention in CKD stages 3-5.
Extreme Cholesterol (>7.5 mmol/L)
Suggests monogenic or familial hyperlipidemia requiring specialized evaluation.
Urgent investigation for secondary causes or genetic FH screening.
Ages Under 25 or Over 84 Years
The QRISK3 dataset was developed and validated strictly for individuals aged 25 to 84.
Clinical judgment based on physiological status and overall health frailty.
Evidence-Based NHS Strategies to Lower Your QRISK Score
If your NHS Health Check reveals an elevated or high QRISK score, there is immense scope to actively reduce your risk. While non-modifiable factors (age, genetic heritage, biological sex) cannot be altered, modifying your lifestyle delivers dramatic clinical dividends:
1. Complete Smoking Cessation
Tobacco smoke accelerates arterial endothelial damage, causes blood platelet clumping, and promotes coronary spasm. Within 1 year of quitting smoking, your excess risk of heart attack drops by approximately 50%, producing an immediate drop in your mathematical QRISK score.
2. Blood Pressure Optimization
Every 10 mmHg reduction in systolic blood pressure reduces your relative risk of stroke by 27% and ischemic heart disease by 17%. Utilize our blood pressure chart UK to monitor your numbers at home. Limiting dietary salt to under 6 grams per day (around one level teaspoon) can lower systolic pressure by 5 to 8 mmHg.
3. Targeted Weight Loss & Visceral Fat Reduction
Carrying excess visceral fat inside the abdominal cavity causes chronic systemic inflammation, insulin resistance, and atherogenic dyslipidemia. Losing 5% to 10% of your initial body weight via an evidence-based calorie deficit calculator plan substantially improves your cholesterol ratio and lowers your QRISK heart age. Follow a safe rate of weight loss per week (0.5 kg to 1 kg) for permanent vascular benefits.
4. The Mediterranean Dietary Pattern
Adopt a cardioprotective diet rich in oily fish (salmon, mackerel for omega-3 fatty acids), whole grains, pulses, leafy greens, nuts, seeds, and extra virgin olive oil. Replace saturated dairy and animal fats with monounsaturated and polyunsaturated fats to lower your total-to-HDL cholesterol ratio.
5. Structured Physical Activity
The NHS recommends at least 150 minutes of moderate-intensity aerobic exercise (such as brisk walking, cycling, or swimming) or 75 minutes of vigorous exercise each week, supplemented by two strength-training sessions. Regular aerobic exercise improves arterial compliance and boosts protective HDL cholesterol.
Frequently Asked Questions About QRISK Scores
Here are clear, evidence-based answers to the most common questions asked by patients across the NHS regarding cardiovascular risk screening:
A QRISK score is an evidence-based clinical algorithm developed in the UK (by the University of Nottingham and ClinRisk Ltd) that estimates your percentage probability of having a major cardiovascular event—specifically a stroke, transient ischaemic attack (TIA), myocardial infarction (heart attack), or angina—over the next 10 years. It is the official screening tool used across the NHS.
In clinical terms, a QRISK score below 10% is categorized as 'low risk'. This means you have less than a 1 in 10 chance of suffering a stroke or heart attack over the coming decade. However, because age is the single strongest driver of absolute cardiovascular risk, older adults (such as someone aged 75) will naturally have higher absolute scores even with pristine blood pressure and cholesterol. Therefore, doctors also assess 'relative risk' or 'heart age' to determine whether your score is normal for someone of your demographic background.
Under NICE guideline NG238 (Cardiovascular disease: risk assessment and reduction), a 10-year QRISK score of 10% or higher is the threshold where preventative lipid-lowering medication (such as Atorvastatin 20mg daily) demonstrates proven, cost-effective clinical benefit in preventing first-time cardiovascular events. Above 10%, the number of heart attacks and strokes prevented substantially outweighs the minimal incidence of drug side effects.
QRISK3 is the updated, highly refined version of QRISK2. While QRISK2 evaluated traditional risk factors (age, sex, ethnicity, blood pressure, cholesterol ratio, BMI, smoking, diabetes, and family history), QRISK3 adds vital clinical conditions that accelerate vascular aging. These include chronic kidney disease (CKD stages 3-5), systemic lupus erythematosus (SLE), rheumatoid arthritis, severe mental illness (schizophrenia, bipolar disorder, severe depression), erectile dysfunction, systemic corticosteroids, atypical antipsychotics, and blood pressure variability.
Yes, significantly. While you cannot alter non-modifiable factors like age, sex, or genetics, modifiable factors make an enormous difference. Quitting smoking halves excess cardiovascular risk within 1 to 2 years. Reducing systolic blood pressure by 10 mmHg lowers stroke risk by ~27%. Lowering your cholesterol ratio and reducing excess visceral body fat toward a healthy BMI (18.5–24.9) can drop your overall 10-year percentage risk and substantially lower your biological heart age.
NICE explicitly advises against using QRISK for patients who already have established cardiovascular disease (previous heart attack, stroke, TIA, angina, or peripheral vascular disease), patients with diagnosed Familial Hypercholesterolaemia (FH), severe hypercholesterolemia (total cholesterol >7.5 mmol/L), Type 1 diabetes over age 40 or with nephropathy, or severe chronic kidney disease (eGFR <60 ml/min/1.73m²). These individuals are already classified as high risk and require immediate clinical secondary prevention without calculating a score.
Related NHS Cardiovascular & Health Tools
Explore our suite of evidence-based calculators and clinical guides to monitor your cardiovascular metrics and body composition:
This clinical explainer adheres strictly to published guidance and peer-reviewed research from leading UK health institutions:
National Institute for Health and Care Excellence (NICE):Cardiovascular disease: risk assessment and reduction, including lipid modification (NICE guideline NG238). Replaces CG181.
ClinRisk Ltd & University of Nottingham:QRISK3-2017: Risk calculator for cardiovascular disease risk assessment in UK general practice (Hippisley-Cox J et al., BMJ 2017).
British Heart Foundation (BHF):Understanding Your Risk of Heart and Circulatory Diseases & Statins Explained.
NHS England:NHS Health Check Programme Overview & Cardiovascular Risk Assessment Standards. Available at nhs.uk.
MHRA (Medicines and Healthcare products Regulatory Agency):Statins: Benefits and Risks in Cardiovascular Primary Prevention.
Medical Disclaimer: This guide and interactive score interpreter are designed strictly for educational and public health informational purposes. They do not constitute individualized medical advice, clinical diagnosis, or a prescription recommendation. Your formal QRISK score must be calculated and interpreted in consultation with an NHS general practitioner or registered healthcare professional who can review your complete medical records, lipid blood tests, and family history. Never start, discontinue, or alter prescribed medication (such as statins or antihypertensives) without consulting your prescribing doctor.